Mind Medicine (MindMed) Inc. (MNMD)
NASDAQ: MNMD · Real-Time Price · USD
5.65
-0.13 (-2.17%)
At close: Apr 21, 2025, 4:00 PM
5.69
+0.05 (0.80%)
After-hours: Apr 21, 2025, 5:01 PM EDT
Mind Medicine (MindMed) Market Cap
Mind Medicine (MindMed) has a market cap or net worth of $426.58 million as of April 21, 2025. Its market cap has decreased by -48.50% in one year.
Market Cap
426.58M
Enterprise Value
174.70M
1-Year Change
-48.50%
Ranking
Category
Stock Price
$5.65
Market Cap Chart
Since March 4, 2020, Mind Medicine (MindMed)'s market cap has decreased from $595.37M to $426.58M, a decrease of -28.35%. That is a compound annual growth rate of -6.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2025 | 434.88M | -14.80% |
| Dec 31, 2024 | 510.39M | 247.80% |
| Dec 29, 2023 | 146.75M | 77.54% |
| Dec 30, 2022 | 82.66M | -85.99% |
| Dec 31, 2021 | 590.17M | -82.89% |
| Dec 31, 2020 | 3.45B | 479.23% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 740.81B |
| UnitedHealth Group | 398.16B |
| Johnson & Johnson | 379.62B |
| AbbVie | 303.61B |
| Novo Nordisk | 284.50B |
| Abbott Laboratories | 227.79B |
| Novartis AG | 209.93B |
| AstraZeneca | 208.11B |